Leading Companies Reinforce Their Presence in the Continuous Glucose Monitor System Market

The continuous glucose monitor system market is poised for significant expansion as healthcare technology advances and diabetes management becomes more personalized. With innovations that integrate digital health platforms and wearable devices, this industry is set to transform patient care and monitoring approaches in the coming years. Let's explore the market's expected growth, leading players, emerging trends, and key segments shaping this dynamic field.

Projected Market Growth and Size of the Continuous Glucose Monitor System Industry
The continuous glucose monitor system market is on track for rapid development, with its valuation expected to reach $19.18 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 14.8%. Several factors contribute to this growth, including the rising adoption of closed-loop insulin delivery systems that automate glucose management, greater demand for remote patient monitoring, and the expansion of personalized diabetes care solutions. Additionally, increasing integration with digital health platforms and a stronger focus on non-invasive glucose sensing technologies are fueling market momentum. Key trends anticipated to influence the market include the widespread adoption of smartphone-integrated CGM systems, the growing use of real-time glucose monitoring solutions, advances in AI-driven glucose analytics, proliferation of wearable sensor technologies, and a heightened emphasis on continuous patient monitoring.

Download a free sample of the continuous glucose monitor system market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20732&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Companies Making an Impact in the Continuous Glucose Monitor System Market
Several prominent organizations dominate the continuous glucose monitor system industry. These include Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., and DarioHealth Corp. Other notable players include Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, and Nipro Diagnostics UK Limited.
In a significant development in August 2024, Abbott partnered with Medtronic plc. to develop an integrated continuous glucose monitoring system. This collaboration aims to enhance diabetes management for millions of patients worldwide, particularly those dependent on intensive insulin therapies. Medtronic, based in Ireland, is a well-known provider of CGM devices, making this partnership a strategic move in advancing patient care.

Emerging Trends Shaping the Continuous Glucose Monitor System Industry
Key market players are increasingly focusing on creating advanced over-the-counter (OTC) continuous glucose monitors to improve accessibility and broaden use beyond prescription-based users. OTC CGMs provide real-time glucose tracking without the need for a doctor's prescription, making them convenient for consumers who wish to self-monitor.
For example, in September 2024, Abbott Laboratories introduced Lingo in the U.S., targeting adults without diabetes. This device allows users to monitor glucose levels and gain insights into how diet and exercise impact their health. Lingo's wearability of up to 14 days supports Abbott's goal of tapping into the growing prediabetes and wellness market, offering consumers a non-prescription option for glucose monitoring.

View the full continuous glucose monitor system market report:
https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitor-system-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Breakdown of Market Segments and Forecast in the Continuous Glucose Monitor System Industry
The continuous glucose monitor system market is segmented based on various factors to provide a detailed understanding of its structure and growth prospects:
1) By Component: Transmitters, Receivers, Sensors
2) By Technology: Real-Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring
3) By Demography: Child Population, Adult Population
4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes
5) By End-User: Diagnostic Centers, Hospitals, Clinics, Intensive Care Units (ICUs), Home Healthcare
Further subcategories include types of transmitters such as Bluetooth-enabled and wireless transmitters; receivers differentiated as dedicated CGM devices, smartphone-based receivers, and cloud-connected receivers; and sensors classified into enzyme-based, non-enzyme-based, and electrochemical sensors. This segmentation helps highlight the diverse technology options and user groups driving the market's development.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.